BCM
BTAL icon

Brookstone Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Brookstone Capital Management’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,596,823
Closed -$54M – 830
2023
Q1 		$54M Sell
2,596,823
-81,301
-3% -$1.64M 1.05% 15
2022
Q4 		$57.4M Buy
2,678,124
+1,820,316
+212% +$37.7M 1.16% 13
2022
Q3 		$17.6M Buy
+857,808
New +$17.1M 0.41% 67

Other funds holding BTAL

TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
APA
Astoria Portfolio Advisors New York $470M AUM 21.04% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Brookstone Capital Management's BTAL Position: Q2 2023 in Review

Brookstone Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 2,596,823 shares — an estimated $54M sold.

Brookstone Capital Management first reported a position in BTAL in Q3 2022 and held it in 3 quarters. The position peaked at $57.4M in Q4 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Brookstone Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Brookstone Capital Management sold 2,596,823 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $54M.
  • Brookstone Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 3 quarters.
  • Brookstone Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $57.4M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Brookstone Capital Management's 13F filing for Q2 2023, filed 11 Jul 2023.